论文部分内容阅读
目的:观察和研究对于冠心病伴心理障碍患者使用抗焦虑抑郁药物进行治疗的效果。方法:选择患有冠心病伴心理障碍的患者一共120例,将这些患者分为三组,观察组A组患者在进行常规治疗的同时使用米氮平进行治疗,观察组B组使用黛力新进行治疗,对照组患者仅使用常规治疗方法,对两组患者治疗的效率以及焦虑抑郁的状态进行观察和对比。结果:使用抗抑郁焦虑药物进行治疗的患者,焦虑以及抑郁的负面情绪得到了明显的改善,并且两组患者疾病的症状也有了显著改善。结论:冠心病伴心理障碍患者,在疾病的早期使用抗焦虑抑郁药物进行治疗有很好的治疗效果。
Objective: To observe and study the effect of anti-anxiety and depression treatment in patients with coronary heart disease and psychological disorders. Methods: A total of 120 patients with coronary heart disease and psychological disorders were selected. The patients were divided into three groups. Patients in observation group A were treated with mirtazapine while conventional treatment. Observation group B was treated with dextrose The patients in the control group were treated with conventional treatment only. The efficiency of treatment and the state of anxiety and depression in the two groups were observed and compared. Results: In patients treated with anti-depression and anxiety drugs, anxiety and depression negative emotions have been significantly improved, and the symptoms of the two groups of patients have also been significantly improved. Conclusion: Coronary heart disease patients with mental disorders, the early use of anti-anxiety drugs in the treatment of diseases have a very good therapeutic effect.